Status:
COMPLETED
IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
Lead Sponsor:
Northwestern University
Conditions:
Pain
Obesity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative...
Eligibility Criteria
Inclusion
- ASA I, II,III;
- BMI \> 35 kg/m2,
- Age between 18-70,
- Fluent in English,
- Patients undergoing laparoscopic gastric bypass,
- EKG within 3 months.
Exclusion
- History of allergy to local anesthetics,
- History of chronic opioid use,
- Pregnant patients,
- History of EKG abnormalities.
- Dropout: Conversion to open, patient or surgeon request.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01180660
Start Date
June 1 2010
End Date
November 1 2012
Last Update
August 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611